Elevance Health (NYSE:ELV) has been analyzed by 16 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 5 | 11 | 0 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 1 | 4 | 0 | 0 | 0 |
| 2M Ago | 0 | 0 | 0 | 0 | 0 |
| 3M Ago | 4 | 6 | 0 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $605.69, a high estimate of $649.00, and a low estimate of $557.00. Surpassing the previous average price target of $590.17, the current average has increased by 2.63%.
Breaking Down Analyst Ratings: A Detailed Examination
The standing of Elevance Health among financial experts becomes...
ログインすると全部閲覧できます。
ログイン